Journal of Rheumatic Diseases

Table. 6.

DMARDs prescription patterns at recent outpatient clinic visit according to DMARDs prescription pattern right after cancer diagnosis

DMARDs prescription patterns Discontinuation (n=7) Switching or Maintenance (n=18)
No DMARD (n=4) 1 (14.3) 3 (16.7)
csDMARDs (n=14) 3 (42.8) 11 (61.1)
Monotherapy (all MTX) (n=3) 1 2
Combination MTX (+) (n=8) 2 6
MTX (–) (n=3) 0 3
Biologics (n=7) 3 (42.8) 4 (22.2)

Values are presented as number (%) or number only. DMARDs: disease modifying anti-rheumatic drugs, csDMARDs: conventional synthetic DMARDs, MTX: methotrexate.

J Rheum Dis 2022;29:162~170 https://doi.org/10.4078/jrd.2022.29.3.162
© J Rheum Dis